Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the rhythm-af study)

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 480-484

  Lip, Gregory Y H ^a   Gitt, Anselm K ^b   Le Heuzey, Jean Yves ^c   Bash, Lori D ^d   Morabito, Christopher J ^d   Bernhardt, Alexandra A ^e   Sisk, Christine McCrary ^d   Chazelle, François ^f   Crijns, Harry J ^g  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

^f MSD France   (France)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN;

ADULT; AGED; ALGORITHM; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRADYCARDIA; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DEATH; DISEASE DURATION; DISEASE REGISTRY; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; STROKE PATIENT; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84892566561     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.036     Document Type: Article

References (12)

1. R. Nieuwlaat, S.B. Olsson, G.Y. Lip, A.J. Camm, G. Breithardt, A. Capucci, J.G. Meeder, M.H. Prins, S. Lévy, H.J. Crijns Euro Heart Survey Investigators Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation Am Heart J 153 2007 1006 1012
2. A.J. Camm, G.Y.H. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, and P. Kirchhof 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation Eur Heart J 33 2012 2719 2747
3. J.J. You, D.E. Singer, P.A. Howard, D.A. Lane, M.H. Eckman, M.C. Fang, E.M. Hylek, S. Schulman, A.S. Go, M. Hughes, F.A. Spencer, W.J. Manning, J.L. Halperin, and G.Y. Lip American College of Chest Physicians. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 Suppl 2 2012 e531S e575S
4. R. Nieuwlaat, T. Dinh, S.B. Olsson, A.J. Camm, A. Capucci, R.G. Tieleman, G.Y. Lip, H.J. Crijns Euro Heart Survey Investigators Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 29 2008 915 922
5. R. Pisters, R. Nieuwlaat, M.H. Prins, J.Y. Le Heuzey, A.P. Maggioni, A.J. Camm, H.J. Crijns Euro Heart Survey Investigators Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey Europace 14 2012 666 674
6. M.M. Gallagher, B.J. Hennessy, N. Edvardsson, C.M. Hart, M.S. Shannon, O.A. Obel, N.M. Al-Saady, and A.J. Camm Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion J Am Coll Cardiol 40 2002 926 933
7. A. Pollak, and R.H. Falk Aggravation of postcardioversion atrial dysfunction by sotalol J Am Coll Cardiol 25 1995 665 671
8. G.Y. Lip, J. Zarifis, R.D. Watson, and D.G. Beevers Physician variation in the management of patients with atrial fibrillation Heart 75 1996 200 205
9. H.J. Crijns, L.D. Bash, F. Chazelle, J.Y. Le Heuzey, T. Lewalter, G.Y. Lip, A.P. Maggioni, A. Martín, P. Ponikowski, M. Rosenqvist, P. Sanders, M. Scanavacca, A.A. Bernhardt, S. Unniachan, H.M. Phatak, and A.K. Gitt RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers BMC Cardiovasc Disord 12 2012 85
10. A.L. Klein, R.A. Grimm, S.E. Jasper, R.D. Murray, C. Apperson-Hansen, E.A. Lieber, I.W. Black, R. Davidoff, R. Erbel, J.L. Halperin, D.A. Orsinelli, T.R. Porter, M.F. Stoddard ACUTE Steering and Publications Committee for the ACUTE Investigators Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial Am Heart J 151 2006 380 389
11. I.C. Van Gelder, H.J. Crijns, R.G. Tieleman, J. Brügemann, P.J. De Kam, A.T. Gosselink, F.W. Verheugt, and K.I. Lie Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation Arch Intern Med 156 1996 2585 2592
12. C.S. Elayi, M.G. Whitbeck, R. Charnigo, J. Shah, T.E. Macaulay, G. Morales, J.C. Gurley, B. Kakavand, S. Thal, C.K. Ching, Y. Khaykin, A. Verma, C. Barrett, R. Bai, L. Di Biase, A. Patwardhan, D.J. Moliterno, A. Natale AFFIRM Study Investigators Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study Circ Arrhythm Electrophysiol 4 2011 465 469